FUSION ANTIBODIES PLC ORD 4P吧
排序：
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
20 0 公告 Update on negotiations with NCI regarding OptiMAL FUSION ANTIBODIE资讯 12-19 15:23
26 0 公告 Launch of OptiMAL platform FUSION ANTIBODIE资讯 12-16 19:07
23 0 公告 Mammalian Display video FUSION ANTIBODIE资讯 12-11 15:26
26 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 11-25 20:19
26 0 公告 Half-year Financial Report FUSION ANTIBODIE资讯 11-24 15:21
25 0 公告 Notice of Results FUSION ANTIBODIE资讯 11-21 15:23
22 0 公告 OptiMAL Library video FUSION ANTIBODIE资讯 11-13 15:25
33 0 公告 OptiMAL？ R&D Update FUSION ANTIBODIE资讯 11-03 15:35
32 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 10-28 00:01
24 0 公告 Result of AGM FUSION ANTIBODIE资讯 10-16 20:34
27 0 公告 AGM statement and H1 trading update FUSION ANTIBODIE资讯 10-16 14:23
38 0 公告 Contract win FUSION ANTIBODIE资讯 10-08 14:16
40 0 公告 Posting of Annual Report & Notice of AGM FUSION ANTIBODIE资讯 09-19 20:01
27 0 公告 OptiMAL R&D Update FUSION ANTIBODIE资讯 09-17 14:18
30 0 公告 Belfast investor presentation FUSION ANTIBODIE资讯 09-08 14:31
26 0 公告 Final Results FUSION ANTIBODIE资讯 09-04 14:17
32 0 公告 Contract Win FUSION ANTIBODIE资讯 08-28 14:29
22 0 公告 Contract wins with existing client FUSION ANTIBODIE资讯 08-27 14:22
33 0 公告 Investor presentations FUSION ANTIBODIE资讯 08-26 14:45
37 0 公告 Grant of U.S. Patent for OptiMAL FUSION ANTIBODIE资讯 08-05 14:32
31 0 公告 Issue Notification: US Patent Update FUSION ANTIBODIE资讯 07-24 18:00
33 0 公告 Director/PDMR Shareholding FUSION ANTIBODIE资讯 07-11 14:13
48 0 公告 Total Voting Rights FUSION ANTIBODIE资讯 06-02 14:20
33 0 公告 Update on U.S. Patent for OptiMAL？ FUSION ANTIBODIE资讯 05-22 21:36
44 0 公告 Investor presentation FUSION ANTIBODIE资讯 05-08 14:59
36 0 公告 Issue of shares to non-executive directors FUSION ANTIBODIE资讯 05-07 14:17
40 0 公告 Director/PDMR Shareholding FUSION ANTIBODIE资讯 05-06 17:56
44 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 05-06 17:43
32 0 公告 Trading update FUSION ANTIBODIE资讯 05-06 14:44
46 0 公告 Total Voting Rights FUSION ANTIBODIE资讯 05-01 00:03
39 0 公告 Approval of grant funding FUSION ANTIBODIE资讯 04-24 14:15
35 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 04-11 17:45
40 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 04-10 19:50
37 0 公告 Result of General Meeting FUSION ANTIBODIE资讯 04-07 19:42
54 0 公告 Total Voting Rights FUSION ANTIBODIE资讯 04-01 00:02
39 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 03-25 00:41
42 0 公告 Placing to raise approximately ￡1.17 million FUSION ANTIBODIE资讯 03-18 15:18
39 0 公告 Contract win FUSION ANTIBODIE资讯 02-27 15:18
59 0 公告 OptiMAL R&D Update FUSION ANTIBODIE资讯 01-31 15:12
72 0 公告 Approval of Grant Funding Application FUSION ANTIBODIE资讯 12-04 19:34
74 0 公告 Half-year Report FUSION ANTIBODIE资讯 11-19 15:15
69 0 公告 Director/PDMR Shareholding FUSION ANTIBODIE资讯 10-16 20:28
73 0 公告 Issue of shares to non-executive directors FUSION ANTIBODIE资讯 10-16 14:12
66 0 公告 Result of AGM FUSION ANTIBODIE资讯 10-08 19:35
80 0 公告 AGM statement and trading update FUSION ANTIBODIE资讯 10-08 14:20
71 0 公告 Block admission six monthly return FUSION ANTIBODIE资讯 10-02 14:12
73 0 公告 Notice of AGM FUSION ANTIBODIE资讯 09-12 16:57
83 0 公告 Director/PDMR Shareholding FUSION ANTIBODIE资讯 09-09 19:38
76 0 公告 Investor presentation FUSION ANTIBODIE资讯 09-09 14:19
81 0 公告 Director/PDMR Shareholding FUSION ANTIBODIE资讯 09-05 19:18
76 0 公告 Final Results FUSION ANTIBODIE资讯 09-05 14:12
85 0 公告 Expansion to OptiMAL collaboration agreement FUSION ANTIBODIE资讯 08-28 15:12
74 0 公告 Director/PDMR Shareholding FUSION ANTIBODIE资讯 07-22 21:02
67 0 公告 Launch of New Interactive Investor Hub FUSION ANTIBODIE资讯 07-18 15:08
99 0 公告 Trading update FUSION ANTIBODIE资讯 07-04 15:08
60 0 公告 New contract with existing client FUSION ANTIBODIE资讯 05-23 15:08
71 0 公告 Investor presentation FUSION ANTIBODIE资讯 05-02 15:23
82 0 公告 Year-end trading statement FUSION ANTIBODIE资讯 04-30 15:13
80 0 公告 Change of auditor FUSION ANTIBODIE资讯 04-16 15:07
76 0 公告 Contract to develop a bespoke OptiPhage library FUSION ANTIBODIE资讯 04-15 15:12
71 0 公告 Block admission six monthly return FUSION ANTIBODIE资讯 04-02 22:45
74 0 公告 Total Voting Rights FUSION ANTIBODIE资讯 03-29 02:06
80 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 03-12 00:17
67 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 03-11 18:18
73 0 公告 Holding(s) in Company FUSION ANTIBODIE资讯 03-09 00:17
95 0 公告 Result of General Meeting and Total Voting Rights FUSION ANTIBODIE资讯 03-05 19:47
89 0 公告 Total Voting Rights FUSION ANTIBODIE资讯 03-01 02:07
85 0 公告 First purchase order under MSA FUSION ANTIBODIE资讯 02-27 16:08
97 0 公告 Grant of options and issue of shares to directors FUSION ANTIBODIE资讯 02-14 16:23
87 0 公告 Placing to raise ￡1,375,000 FUSION ANTIBODIE资讯 02-14 16:08
89 0 公告 Follow-on project award and R&D update FUSION ANTIBODIE资讯 02-06 16:07
87 0 公告 HMRC R&D tax credit FUSION ANTIBODIE资讯 02-01 16:44
88 0 公告 Director/PDMR Shareholding FUSION ANTIBODIE资讯 12-04 21:32
104 0 公告 Half-year Report FUSION ANTIBODIE资讯 12-04 16:10
97 0 公告 OptiMAL collaboration agreement FUSION ANTIBODIE资讯 11-28 16:10
78 0 公告 Half year trading update FUSION ANTIBODIE资讯 11-09 16:38
98 0 公告 Result of AGM FUSION ANTIBODIE资讯 10-27 20:03
107 0 公告 Block admission six monthly return FUSION ANTIBODIE资讯 10-04 22:53
119 0 公告 Final Results FUSION ANTIBODIE资讯 09-29 15:09
84 0 公告 Update on AI/ML-Ab service offering FUSION ANTIBODIE资讯 08-29 15:08
发表新主题
悬赏提问
帖子不见了！怎么办？   
   请登录 登录 | 5秒注册 作者： 退出 
温馨提示： 1.根据《证券法》规定，禁止编造、传播虚假信息或者误导性信息，扰乱证券市场；2.用户在本社区发表的所有资料、言论等仅代表个人观点，与本网站立场无关，不对您构成任何投资建议。用户应基于自己的独立判断，自行决定证券投资并承担相应风险。《东方财富社区管理规定》
东方财富

扫一扫下载APP
东方财富产品
证券交易
关注东方财富
天天基金

扫一扫下载APP
基金交易
关注天天基金
东方财富期货

扫一扫下载APP
期货交易
信息网络传播视听节目许可证：0908328号 经营证券期货业务许可证编号：913101046312860336 违法和不良信息举报:021-34289898 举报邮箱：jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:021-54509966/952500
关于我们 广告服务 联系我们 诚聘英才 免责声明 法律声明 隐私保护 征稿启事 放心搜 友情链接